Olema Pharmaceuticals, Inc. (OLMA)

NASDAQ: OLMA · Real-Time Price · USD

12.05

+0.25 (2.12%)

At close: Aug 7, 2026, 4:00 PM EDT

12.10

+0.05 (0.41%)

Pre-market: Aug 10, 2026, 8:08 AM EDT

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.55	48.3	139.48	68.54	23.7	13.81
Short-Term Investments	452.8	457.14	294.61	193.27	180.72	273.44
Cash & Short-Term Investments	505.35	505.44	434.09	261.81	204.42	287.25
Cash Growth	28.68%	16.44%	65.80%	28.07%	-28.84%	-15.15%
Other Current Assets	7.88	10.02	4.39	4.71	4.48	3.44
Total Current Assets	513.23	515.45	438.47	266.51	208.9	290.69
Net Property, Plant & Equipment	17.42	17.98	12.51	10.43	6.75	5.26
Total Assets	530.65	533.43	450.98	276.95	215.65	295.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.72	9.25	4.46	2.7	0.37	0.02
Accrued Expenses	42.49	41.43	36.13	17.94	15.16	8.07
Current Portion of Leases	0.96	1.12	1.17	0.99	1.02	0.93
Total Current Liabilities	47.17	51.8	41.76	21.62	16.55	9.02
Long-Term Debt	3	3	-	-	-	-
Long-Term Leases	-	0.07	0.26	1.43	1.55	2.36
Total Long-Term Liabilities	3	3.07	0.26	1.43	1.55	2.36
Total Liabilities	50.17	54.87	42.02	23.05	18.1	11.38

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	1,132	1,075	843.92	559.18	408.33	388.9
Accumulated Other Comprehensive Income	-0.46	0.62	0.14	0.35	-1.81	-0.15
Retained Earnings	-650.65	-597.56	-435.11	-305.63	-208.98	-104.19
Shareholders' Equity	480.48	478.56	408.96	253.9	197.55	284.57
Total Liabilities & Equity	530.65	533.43	450.98	276.95	215.65	295.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	3.96	4.19	1.43	2.42	2.57	3.29
Net Cash (Debt)	501.39	501.24	432.66	259.39	201.86	283.96
Net Cash Growth	28.05%	15.85%	66.80%	28.50%	-28.91%	-16.12%
Net Cash Per Share	5.49	5.76	7.37	5.73	5.05	7.18
Book Value	480.48	478.56	408.96	253.9	197.55	284.57
Book Value Per Share	5.26	5.50	6.96	5.61	4.94	7.20
Tangible Book Value	480.48	478.56	408.96	253.9	197.55	284.57
Tangible Book Value Per Share	5.26	5.50	6.96	5.61	4.94	7.20

SEC Filings: 10-K · 10-Q